Advertisement
Intravenous antibiotics do not achieve greater sustained eradication of Pseudomonas aeruginosa in patients with cystic fibrosis compared with oral therapy

IV, Oral Antibiotics Comparable for Treating P. aeruginosa in CF

0
Results do not support use of IV antibiotics to eradicate P. aeruginosa in cystic fibrosis, authors say
COVID-19 symptoms are prolonged in pregnant women and persist for eight or more weeks in 25 percent

COVID-19 Symptoms Often Prolonged in Pregnant Women

0
Most prevalent first symptoms cough, sore throat, body aches, fever for those testing positive for SARS-CoV-2
The lifetime prevalence of suicide ideation is 17.4 percent among physicians

Lifetime Prevalence of Suicide Ideation 17.4 Percent Among Doctors

0
Lifetime prevalence of suicide attempts 1.8 percent, with one-year prevalence of 0.3 percent
Neurologic manifestations are common in COVID-19

Neurologic Manifestations Seen in Most Hospitalized With COVID-19

0
Encephalopathy, seen in 31.8 percent of hospitalized patients, tied to worse functional outcome, mortality
Lopinavir-ritonavir is not associated with reductions in 28-day mortality or duration of hospital stay among patients admitted to the hospital with COVID-19

Lopinavir-Ritonavir No Benefit in Patients Admitted With COVID-19

0
No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir
The overall prevalence of venous thromboembolism in patients with COVID-19 is estimated to be 14.1 percent

Review: Estimated Prevalence of VTE 14.1 Percent in COVID-19

0
Venous thromboembolism found in 7.9 percent of non-ICU patients, 22.7 percent of ICU patients
Following weeks of delay

White House Approves Tougher Rules for COVID-19 Vaccine Development

0
Guidelines recommend participants in late-stage trials be followed for a median of at least two months
Records for COVID-19 hospitalizations were set Tuesday in six states -- Arkansas

Six States Set Records for COVID-19 Hospitalizations

0
Wyoming's 36.7 percent increase since last week in its rolling seven-week average was the largest of any state
Eli Lilly and Co. is seeking U.S. approval for emergency use of an experimental antibody therapy for COVID-19.

Company Seeks FDA Emergency Approval for COVID-19 Antibody Therapy

0
Request based on partial clinical trial findings suggesting the drug reduces symptoms in mild or moderate COVID-19
Avoiding cow's milk formula supplementation at birth may prevent asthma or recurrent wheeze in young children

Avoiding Cow’s Milk Baby Formula May Cut Asthma, Wheezing Later

0
Avoiding supplementation with cow's milk formula for at least the first three days of life may lower risk